PCRX•benzinga•
HC Wainwright & Co. Maintains Buy on Pacira BioSciences, Raises Price Target to $70
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on February 28, 2025 by benzinga